Protherics is a biopharmaceutical company that manufactures DigiFab used for overdose treatment &a; other hospital products for critical care.
Business Model:
Revenue: $0
Employees: 0-0
Protherics was acquired by
BTG International.
The acquisition happend on 2008-09-18.
Details of the transaction were not public
Address:
City: Runcorn
State: Cheshire
Zip:
Country: United Kingdom
Protherics is a biopharmaceutical company that develops, manufactures and markets specialized hospital products for critical care and cancer primarily in the United Kingdom, the United States, and Australia. The company offers various products for application in medical emergencies, such as overdose, poisoning, and life-threatening infections. It offers critical care products, which include CroFab, a polyclonal antibody fragment that neutralizes venom from North American Crotalid snakes; DigiFab, a polyclonal antibody fragment for the treatment of life-threatening digoxin toxicity or overdose; CytoFab, which is used in the treatment of severe sepsis; and ViperaTAb, a venom antidote product for the treatment of snakebites; and Digoxin Immune Fabs, which are polyclonal antibody fragments used in the treatment of pre-eclampsia, a complication of pregnancy.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|